Clinical Trials Directory

Trials / Completed

CompletedNCT02079597

The Role of Ninjurin-1 During Systemic Inflammation

Prospective Study to Analyze Ninjurin-1 and Its Soluble Part During Systemic Inflammation

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Dr. Patrick Meybohm, M.D. · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

* With the underlying study the investigators address the question if Ninjurin-1 (Ninj1) expression is altered in patients with systemic inflammatory response syndrome (SIRS) in comparison to healthy volunteers. * The adhesion molecule Ninj1 is induced following nerve injury where it contributes to nerve generation. Besides it is described to facilitate leukocyte migration especially in the nervous system. * The investigators hypothesize that Ninj1 expression is increased in SIRS patients, which will fortify its impact during inflammation and the transferability from bench to bedside.

Conditions

Timeline

Start date
2014-02-01
Primary completion
2014-06-01
Completion
2014-09-01
First posted
2014-03-06
Last updated
2014-09-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02079597. Inclusion in this directory is not an endorsement.